Yinchu Cheng

401 total citations
31 papers, 272 citations indexed

About

Yinchu Cheng is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Yinchu Cheng has authored 31 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Yinchu Cheng's work include COVID-19 Clinical Research Studies (3 papers), Lipoproteins and Cardiovascular Health (2 papers) and Genomics and Phylogenetic Studies (2 papers). Yinchu Cheng is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Lipoproteins and Cardiovascular Health (2 papers) and Genomics and Phylogenetic Studies (2 papers). Yinchu Cheng collaborates with scholars based in China, United States and Sweden. Yinchu Cheng's co-authors include Siyan Zhan, Yang Zhang, Jun Ma, Lin Zhuo, Rongsheng Zhao, Jian Lü, Suodi Zhai, Yan Li, Yingying Yan and Honghua Jia and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Microbiology.

In The Last Decade

Yinchu Cheng

30 papers receiving 268 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yinchu Cheng 63 35 31 30 28 31 272
Kyle Raubenheimer 79 1.3× 27 0.8× 8 0.3× 18 0.6× 25 0.9× 10 327
Amy Baker 54 0.9× 14 0.4× 9 0.3× 5 0.2× 59 2.1× 14 557
Peter Kleist 80 1.3× 14 0.4× 30 1.0× 5 0.2× 67 2.4× 26 378
V. A. Metelskaya 73 1.2× 20 0.6× 18 0.6× 4 0.1× 135 4.8× 107 558
Danhui Yi 66 1.0× 19 0.5× 21 0.7× 20 0.7× 16 0.6× 38 358
Khoa A. Nguyen 39 0.6× 30 0.9× 28 0.9× 12 0.4× 51 1.8× 37 279
Kavita Munjal 70 1.1× 39 1.1× 3 0.1× 8 0.3× 35 1.3× 42 369
Manuel Durán Fuentes 67 1.1× 14 0.4× 15 0.5× 13 0.4× 20 0.7× 20 325
Jina Jung 90 1.4× 95 2.7× 12 0.4× 8 0.3× 46 1.6× 37 395

Countries citing papers authored by Yinchu Cheng

Since Specialization
Citations

This map shows the geographic impact of Yinchu Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinchu Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinchu Cheng more than expected).

Fields of papers citing papers by Yinchu Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinchu Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinchu Cheng. The network helps show where Yinchu Cheng may publish in the future.

Co-authorship network of co-authors of Yinchu Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yinchu Cheng. A scholar is included among the top collaborators of Yinchu Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinchu Cheng. Yinchu Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hongsheng, Shuang Liu, Lingling Yu, et al.. (2025). Association between tacrolimus intrapatient variability and clinical outcomes in kidney transplantation: a retrospective cohort study. Translational Andrology and Urology. 14(10). 3203–3211.
2.
Yang, Ping, Wei Liu, Libo Zhao, et al.. (2024). Population pharmacokinetics of nirmatrelvir in Chinese patients with COVID-19: Therapeutic drug monitoring and dosing regimen selection in clinical practice. International Journal of Antimicrobial Agents. 64(2). 107199–107199. 1 indexed citations
3.
He, Na, Yingying Yan, Ziyang Wu, et al.. (2023). Chat GPT-4 significantly surpasses GPT-3.5 in drug information queries. Journal of Telemedicine and Telecare. 31(2). 306–308. 31 indexed citations
4.
Cheng, Yinchu, Kun Zhang, Zhanguo Wang, et al.. (2023). Efficacy and safety of flurbiprofen cataplasms versus loxoprofen sodium cataplasms in knee osteoarthritis: a randomized controlled trial. Chinese Medical Journal. 136(18). 2187–2194. 2 indexed citations
5.
Cheng, Yinchu, et al.. (2023). Effects of time-restricted eating with different eating windows on human metabolic health: pooled analysis of existing cohorts. Diabetology & Metabolic Syndrome. 15(1). 209–209. 6 indexed citations
6.
Cheng, Yinchu, et al.. (2022). Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker. Disease Markers. 2022. 1–19. 11 indexed citations
8.
Tong, Xunliang, Chunping Wang, Yingying Yan, et al.. (2022). Concomitant Medication Use With Xiyanping Injection and the Risk of Suspected Allergic Reactions: A Nested Case–Control Study Based on China’s National Medical Insurance Database. Frontiers in Pharmacology. 13. 883407–883407. 1 indexed citations
9.
Cheng, Yinchu, et al.. (2022). MTDeepM6A-2S: A two-stage multi-task deep learning method for predicting RNA N6-methyladenosine sites of Saccharomyces cerevisiae. Frontiers in Microbiology. 13. 999506–999506. 3 indexed citations
10.
Cheng, Yinchu, Shujie Dong, Peng Shen, et al.. (2022). Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe. Frontiers in Cardiovascular Medicine. 9. 988576–988576. 5 indexed citations
11.
Song, Zaiwei, Lan Ma, Li Bao, et al.. (2022). Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship. Frontiers in Pharmacology. 13. 931495–931495. 2 indexed citations
12.
Ma, Runzhuo, Yinchu Cheng, Pengxiang Zhou, et al.. (2022). Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis. European Urology Open Science. 42. 19–29. 9 indexed citations
13.
Li, Xiaoxiao, Guanru Wang, Na He, et al.. (2022). Severe Thrombocytopenia Caused by Vancomycin in the Intensive Care Unit: A Case Report. Frontiers in Medicine. 9. 829267–829267. 2 indexed citations
14.
Li, Xiaoxiao, Yinchu Cheng, Suodi Zhai, et al.. (2021). Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis. Frontiers in Pharmacology. 12. 589091–589091. 5 indexed citations
15.
Song, Zaiwei, Xinya Li, Yang Hu, et al.. (2021). The implementation of a FIP guidance for COVID-19: insights from a nationwide survey. Annals of Translational Medicine. 9(18). 1479–1479. 3 indexed citations
16.
Zhuo, Lin, et al.. (2020). A Multiview Model for Detecting the Inappropriate Use of Prescription Medication: Machine Learning Approach. JMIR Medical Informatics. 8(7). e16312–e16312. 2 indexed citations
18.
Cheng, Yinchu, et al.. (2019). Expression, characterization, and site-directed mutagenesis of UDP-glycosyltransferase UGT88A1 from Arabidopsis thaliana. Bioengineered. 10(1). 142–149. 13 indexed citations
19.
20.
Cheng, Yinchu, et al.. (2016). Prevalence of mild cognitive impairment in China: a meta-analysis of studies in 2001-2015. Chin J Psychiatry. 49(5). 298–306. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026